Home / Business / Liraglutide and Semaglutide Global Strategic Business Analysis Report 2025-2030: Regulatory Pipeline for Pediatric and Adolescents With Obesity Creates Long-Term Market Opportunities – ResearchAndMark

Business

Liraglutide and Semaglutide Global Strategic Business Analysis Report 2025-2030: Regulatory Pipeline for Pediatric and Adolescents With Obesity Creates Long-Term Market Opportunities – ResearchAndMark

By wpadministrator

No Comments

December 26, 2025 11:55 am

The “Liraglutide and Semaglutide – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Liragl…

DUBLIN–(BUSINESS WIRE)–The “Liraglutide and Semaglutide – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
The global market for Liraglutide and Semaglutide was valued at US$17.1 Billion in 2024 and is p… [11078 chars]

Source: Business Wire | Published: 2025-12-26T11:55:00Z

Credit: Business Wire